price month
solid result seem price us
under-perform larg line result retain under-perform
rate upgrad sales/ep averag
respect incorpor recent bolt-on acquisit kenda
lower tax rate vs due us tax reform well
higher ebit margin also roll dcf
upgrad target price
invest overview underli sale growth line
relev global dental end market ebit margin increas
y/i colten manag deliv respect
result view manag plan invest growth initi
think margin expans becom challeng achiev
especi keep mind achiev result alreadi surpass
manag past mid-term target fact dcf valuat
alreadi assum mid-term ebit margin assum current
strength persist compani benefit product
improv back initi expansionari invest
swiss head offic past year ev/ebitda multipl colten
base year averag share price gone
expans impress still regard rather demand
seen fundament improv growth outlook
eas competit pressur gener dental industri
catalyst risk result due august
valuat get target price use dcf methodolog
assum averag sale growth adj ebit margin
base estim colten stock trade forward
price-to-earnings line compani year
averag
valuat metric
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
colten hold ag switzerland base compani
special dental consum small equip cover
whole dental treatment process work develop
manufactur high-precis impress materi fill
price rate under-perform target price analyst christoph gretler
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
averag underli sale growth go current
assumpt ten year period valuat
current assum midterm averag underli sale growth
declin flat level valuat would
price rel chart measur perform smi price
close
spot exchang rate
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
base revis estim arriv forward price-to-earnings
line year averag
figur rel valuation-european healthcar equip servic
target
roll dcf revis target price assum
year averag sale growth adj ebit margin
tax adj ebit
chang work capit wc
chang asset
invest goodwil
equiti valu per share sfr
oper wc sale
increment capital-expenditure sale
weight averag cost capit
sfr million unless otherwis state
sale growth local currenc
sale growth sfr
rest world
rest world
sfr million unless otherwis state
sale
averag employe
averag wage
sale
sale
gross invest fix asset
depreci
sale
gross fix asset
invest intang
amort acquir intang
amort intang
amort intang
currenc gain loss
compani mention price
